Oncological outcomes of breast cancer patients after planned IORT boost with low-kV x-rays—results of the TARGIT BQR prospective phase IV trial
This phase IV trial confirms previously reported outcomes on upfront IORT boost, with excellent disease-control outcomes.
Authors
- Katharina Fleckenstein
- Frederik Wenz (ORCID: https://orcid.org/0000-0001-6037-0853)
- R. Keymer
- J Pömsl
- Benjamin Tuschy (ORCID: https://orcid.org/0000-0001-9179-3277)
- Sebastian Berlit (ORCID: https://orcid.org/0000-0002-2044-4480)
- Viktoria Brück
- Yasser Abo‐Madyan (ORCID: https://orcid.org/0000-0003-2205-503X)
- Elena Sperk (ORCID: https://orcid.org/0000-0002-8771-8124)
- Marc Sütterlin (ORCID: https://orcid.org/0000-0003-0205-2552)
- Lukas Goerdt
- Christina Kaiser (ORCID: https://orcid.org/0000-0002-2118-4158)
- Uta Kraus-Tiefenbacher
Institutions
- University of Bonn (DE)
- University of Augsburg (DE)
- Heidelberg University (DE)
- University Hospital Bonn (DE)
- University Medical Center Freiburg (DE)
- University Hospital Augsburg (DE)
- University Hospital Heidelberg (DE)
- Krankenhaus Nordwest (DE)
- Klinikum Ludwigsburg (DE)
- Klinikum Kassel (DE)
- University Medical Centre Mannheim (DE)
- Asklepios (DE)
Publication Details
- Journal
- Strahlentherapie und Onkologie
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1007/s00066-025-02412-0
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universität Heidelberg